Syngene International sees strong momentum this fiscal year: MD

Syngene International also expects business growth from its pharma clients who are keen to make up for the time that they felt they lost during the Covid-19 pandemic.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5zLDwi7
via IFTTT